Atia Vision announced today that it received FDA investigational device exemption (IDE) approval to study its OmniVu lens ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface (BCI) ...

The study utilizes the Philips Azurion image-guided therapy system, which offers live X-ray imaging during percutaneous ...

A federal jury has ordered Johnson & Johnson's Biosense Webster business to pay $147 million to a cardiac mapping catheter ...

Merit Medical Systems (Nasdaq:MMSI) announced today that it acquired hemostatic device manufacturer Biolife Delaware.

The room-temperature collagen pad, approved for hemostasis and sealing, features an extended shelf life of three years. It involves the interaction of two components that can create rapid and lasting ...